Gildans Factored Receivables Hidden Channel Stuffing|19% Crash and 3B Wiped

Chapter 1: The Mechanism the Drop Did Not Settle

Gildan Activewear closed down 18.75% on Tuesday, erasing roughly $3 billion in market cap in a single session. The company's guidance remains intact — $6 billion to $6.2 billion in revenue and more than $850 million in free cash flow for fiscal 2026. That combination is the problem, not the answer.

Jehoshaphat Research, a Florida-based short seller, published a 60-page report alleging that Gildan has been stuffing its distribution channel for years — pushing clients to take in more product than they need in a given quarter, then extending payment terms to 90 or 120 days to make the volume stick. The firm holds a short position worth 4 per cent of Gildan's public float.

The mechanism that makes this hard to verify is factoring. Gildan moves a portion of its accounts receivable off the balance sheet by selling them to third parties at a discount. Those buyers collect the receivables and Gildan receives cash upfront. The result is that inflated receivables from channel stuffing do not accumulate visibly on the balance sheet — they disappear into factoring transactions before a quarterly snapshot is taken.

Gildan's response was to reiterate its guidance and state confidence in its disclosure. It did not address the factoring point directly.

That non-denial is what makes the 19% drop insufficient as a verdict. A company that has stuffed its channel would issue exactly the same statement Gildan issued today. A company whose numbers are clean would also issue exactly the same statement. The drop has priced in serious doubt; it has not priced in a confirmed outcome.

Chapter 2: One Prior, Two Paths, One Variable

The reason this cannot be filed away as "wait for earnings" is Jehoshaphat's prior work. In September 2025, the same firm published a similar report on goeasy Ltd., accusing the subprime lender of concealing bad loans. Goeasy denied the allegations. Nine months later, goeasy disclosed a surge in loan losses, suspended its dividend, and its stock is now down 75 per cent from the pre-report level. The pattern is: denial, sustained guidance, then a much larger reset months later when the underlying data surfaces.

UBS analyst Jay Sole reached the opposite conclusion. Citing channel checks and their own modelling, UBS called Tuesday's decline a buying opportunity and said they do not expect a guidance miss. Sole named Gildan's December analyst day as a positive catalyst, not a moment where management would have to explain a large guide-down.

Both readings start from the same 19% decline. UBS sees the valuation gap — GIL now trading at roughly a 43 per cent discount to one intrinsic value estimate and 31 per cent below analyst consensus targets — as the signal. Jehoshaphat sees that gap as irrelevant if the denominator (reported revenue) is inflated. These are not different interpretations of the same risk; they are different beliefs about what the numbers represent.

The HanesBrands acquisition adds a layer the market has not fully priced. Gildan took on approximately $2 billion in net debt when it acquired HanesBrands for $2.2 billion in August 2025. Jehoshaphat argues the Hanes business adds drag to the pro-forma growth profile. If organic revenue has been declining beneath channel stuffing and Hanes is also underperforming, the combined picture materially changes the free cash flow case that justifies the current multiple even at $70.

Two law firms — Rosen Law and Levi and Korsinsky — have opened securities class action investigations. These do not change the underlying accounting question, but they raise the cost of the scenario where the short thesis proves correct: a regulatory inquiry, not just a market repricing.

The variable that resolves this is not the next earnings date but the H2 2026 revenue print against the $6 billion guidance floor. If revenue tracks within range, Jehoshaphat's channel-stuffing thesis collapses. If revenue misses by something approaching the 20 per cent Jehoshaphat projected, the goeasy template becomes the operative one. December's analyst day is the first public forum where management must defend the full-year trajectory with six months of actual data behind it.

For a current holder, the question before acting is whether the factored receivables balance has grown in a pattern inconsistent with underlying demand — data that is not in today's filings but may be inferred from the next receivables disclosure. For a watcher considering entry at $70, the trigger is H2 revenue tracking above $5.8 billion — that level breaks Jehoshaphat's 20 per cent miss scenario and shifts the probability weight toward UBS's view. Until that number exists, the 19% drop resolves nothing that the thesis requires.